Medical
-
An editorial by Monica Kraft in the August 31 online version of the New England Journal of Medicine voices approval for a recent article in the journal describing a study of lebrikizumab treatment for asthma… Read more . . .
-
According to the FDA’s latest update on the ongoing acetylcysteine inhalation solution shortage, all of American Regent/Luitpold’s product is still on back order due to “manufacturing delays,” and the company is still unable to estimate… Read more . . .
-
A randomized, double-blind, Phase 2b dose-ranging study of Pearl Therapeutics’ formoterol fumarate MDI compared to Foradil Aerolizer and placebo showed statistically significant benefits in patients with moderate-to-severe COPD, according to the company. The metered dose… Read more . . .
-
A randomized, double-blind study conducted by researchers from the University of Cincinnati has shown that a capsaicin nasal spray available over the counter significantly relieved nasal congestion, sinus pain, sinus pressure, and headache in patients… Read more . . .
-
British biopharmaceutical company Lightlake Therapeutics has announced that it will begin Phase 2 trials of its naloxone nasal spray for the treatment of binge eating disorder in overweight and obese patients on August 26th, 2011… Read more . . .
-
A study by University of Washington researchers published in the September 2011 issue of Anesthesia & Analgesia, the official journal of the International Anesthesia Research Society, demonstrates improved delivery of morphine and fentanyl in rats… Read more . . .
-
Verona Pharma has successfully completed a Phase 2 study of the duration of bronchodilator action by its lead drug RPL554 in patients with mild asthma, according to the company. RPL554 is a novel long-acting phosphodiesterase… Read more . . .
-
The FDA has approved a pre-market approval (PMA) application from Intersect ENT for its Propel mometasone furoate drug delivery implant for the treatment of chronic sinusitis. The dissolvable device is inserted in the sinus cavity… Read more . . .
-
NexBio, which was recently raided by the US Federal Bureau of Investigation (FBI), has announced results from a Phase 2 clinical trial of its Fludase inhaled antiviral for the treatment of influenza. According to the… Read more . . .
-
After a meeting with the FDA, MannKind Corporation has announced that the company and the agency have confirmed protocols for new efficacy and safety studies of Afrezza inhaled insulin. The original studies of Afrezza were… Read more . . .

Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
December 9-December 11: DDL 2026, Edinburgh, Scotland
April 27-30: RDD Europe 2027, Antibes, France
May 12-13: USP Joint Workshop: Quality and Product Performance Testing of Orally Inhaled and Nasal Drug Products, Rockville, MD, USA
May 30-June 2: ISAM Congress 2027, Dublin, Ireland
June 23: SMI London, London, UK


